Publications by authors named "Guillaume Le Flem"
Bovine hemoglobin is an animal protein described as source of bioactive peptides. Enzymatic hydrolysis of this protein results into some peptides exhibiting antimicrobial activity against Gram-positive and Gram-negative bacteria. In this study, a family of peptides from the beta chain (beta-114-145 derived peptides) obtained by peptic hydrolysis of bovine hemoglobin, was purified by reverse-phase HPLC and characterized by different analytical techniques (mass spectrometry, circular dichroism).
View Article and Find Full Text PDFArticle Synopsis
- The study builds on previous research that showed a synthetic insulin analog (3) can mimic native insulin's effects on cell growth and glucose metabolism.
- New analogs (6, 9, 12) were synthesized to explore which structural features influence their biological activity, revealing that the N-terminal part of these peptides is essential for their effectiveness.
- The findings suggest these mini-insulin variants derived from the A-chain could lead to new treatment strategies for diabetes, possibly offering advantages over traditional insulin.
Sixty-four new indanones and thiaindanones related to donepezil were synthesized and evaluated in vitro as potential AChE inhibitors. Among them, 11 derivatives were found to inhibit the enzyme in the submicromolar range; the best compound revealed its inhibitory activity with an IC50 in the same range (0.06 microM) than the reference compound, donepezil (IC50=0.
View Article and Find Full Text PDFThe design and total synthesis of a novel insulin A-chain mutant, analogue 3, is reported. In this compound, the cysteines implied in the two insulin inter-chain disulfide bridges are replaced by two serines (residues Ser(A7) and Ser(A20)) and the intra-A-chain disulfide bridge (residues Cys(A6) and Cys(A11)) is conserved. This A-chain analogue (3) has been tested in three in vitro cell culture assays, using insulin as a reference.
View Article and Find Full Text PDF